Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
for
Multiple Sclerosis Spasticity
Location: Lewisville TX, Kansas City KS, St Louis MO,
Sponsor: Celgene
Sex: All
Age: 18 - 70
Code: NCT06782490
Phase 2, Recruiting
SW-682 in Advanced Solid Tumors
for
Advanced Solid Tumor, Mesothelioma, Malignant
Location: Dallas TX, Houston TX, Scottsdale AZ, Cleveland OH,
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Sex: All
Age: 18+
Code: NCT06251310
Phase 1, Recruiting
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
for
Aortic Regurgitation, Aortic Valve Insufficiency,
Location: Plano TX, Houston TX, Kansas City MO, St Louis MO,
Sponsor: JenaValve Technology, Inc.
Sex: All
Age: 0+
Code: NCT06608823
Recruiting
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Dallas TX, Los Angeles CA
Sponsor: 1200 Pharma, LLC
Sex: All
Age: 18+
Code: NCT05103046
Phase 1, Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Location: Dallas TX, Fort Worth TX, Tyler TX, Abilene TX,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT05579366
Phase 1, Phase 2, Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
for
Advanced Solid Tumors
Location: Dallas TX, Iowa City IA, Louisville KY, Saint Paul MN,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05719558
Phase 1, Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
for
Alzheimer's Disease
Location: Carrollton TX, Mesquite TX, Cypress TX, San Antonio TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011745
Phase 3, Recruiting
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
for
Cytomegalovirus (CMV)
Location: Fort Worth TX, Houston TX, Omaha NE, Chicago IL,
Sponsor: Takeda
Sex: All
Age: 0 - 17
Code: NCT05319353
Phase 3, Recruiting
HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors
for
Solid Tumors, Adult
Location: Dallas TX
Sponsor: HighField Biopharmaceuticals Corporation
Sex: All
Age: 18 - 70+
Code: NCT05861895
Phase 1, Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Fort Worth TX, San Antonio TX, St Louis MO,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06997029
Phase 1, Recruiting
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: Dallas TX, Houston TX, San Antonio TX, Nashville TN,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06040541
Phase 1, Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
for
Heart Failure
Location: Dallas TX, Houston TX, Amarillo TX, St Louis MO,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 40 - 70+
Code: NCT06979362
Phase 2, Recruiting
Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing
for
ANOCA - Angina With Non-obstructive Coronary Arteries,
Location: Plano TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT06896903
Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)